Trial
NCT02112643
Selenium in Mild Thyroid Eye Disease in North America
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
International Thyroid Eye Disease Society
Condition
Thyroid Associated Ophthalmopathies
Intervention
Sodium selenate
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-18